Gurugram-based digital healthcare platform Clinikally has raised $2.6 million in funding, signaling a significant boost in its mission to transform dermatological healthcare through telehealth technology and online pharmacy services. The funding round, part of Y Combinator’s summer 2022 batch, saw participation from prominent investors, strengthening Clinikally’s position in the competitive healthcare market.
Since its inception in late 2021, Clinikally, founded by Stanford graduate and healthcare researcher Arjun Soin, the startup has provided accessible dermatological care. The platform connects consumers with licensed dermatology practitioners, offering personalized treatment plans for various conditions, including acne, hair loss, eczema, and rosacea.
“By giving a direct channel to qualified physicians and online pharmacy offering established, rigorously tested products, Clinikally’s telehealth platform democratizes access to expert dermatological and wellness care like never before,” said Arjun Soin.
Rapid Expansion and Strategic Collaborations
Clinikally’s innovative approach rapidly gained traction, serving over 450,000 users across 500 cities in just 21 months. The platform’s unique feature generates automated treatment plans through condition-specific diagnostics and questionnaires, ensuring tailored and effective healthcare solutions.
In this latest funding round, key investors like Y Combinator, Tribe Capital, Goodwater Capital, Sequoia Scout Fund, and Rebel Fund, along with notable angel investors such as Arash Ferdowsi, Kunal Shah, and Austen Allred, demonstrated their confidence in Clinikally’s potential.
“We are thrilled to have some truly strategic global investors on board that resonate with the India opportunity; it gives a huge fillip to our mission of reimagining the future of vertically integrated, full-stack care for the specialty in India,” said Soin.
The funds will help to expand the platform, enhance telehealth technology, and strengthen omnichannel capabilities through strategic offline clinic collaborations.
A Unique Offering in a Competitive Landscape
Clinikally’s offerings extend beyond teleconsultations, incorporating many prescription-based skincare, haircare, immunity, wellness, and nutrition-related products. The platform competes with established players like 1mg, Netmeds, and Pharmeasy in product diversity. In telehealth consultations, it rivals Practo and MediBuddy, and in both products and talks, it stands toe-to-toe with Apollo Online.
Clinikally’s revenue streams are twofold. Firstly, its B2C segment operates as a multi-brand online pharmacy and telehealth provider, catering to individual consumer needs. Secondly, in the B2B2C space, Clinically offers private-label products exclusively available in offline clinics, fostering a unique offline-online healthcare ecosystem.
CEO Arjun Soin outlined Clinikally’s ambitious plans to expand its reach to broader demographics, focusing on Tier 2, 3, and 4 cities. The platform intends to enable same-day doorstep delivery across all Tier 1 cities in India, furthering its accessibility. Additionally, Clinikally plans to triple its user base, adding 250 more partner clinics and enhancing its platform’s capabilities.
The recent funding positions the health tech startup as a frontrunner in dermatological telehealth. A user-centric approach and a robust expansion strategy by Clinikally are redefining telehealth and online pharmacy services, making specialized healthcare accessible to millions.
Stay ahead of the curve and follow IndiaTechDesk on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in India.
Read More:
- Atlys Secures $12 Million in Series A Funding to Transform Visa Application Process
- Pilgrim Secures $20 Million in Series B Funding Led by Vertex Ventures
- Kale Logistics Secures $30 Million in Series B Funding Led by Creaegis
- Temasek Continues Support for Electric Vehicle Maker OLA
- Westbridge Capital Leads $21M Series C Investment in DealShare!
